Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Cognoa
CognoaCognoa Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
What is becoming different about Cognoa over time?
Movement over time
Earlier activity concentrated on accuracy quality, adoption state, time saved.
Earlier period
Movement over time
More recent activity concentrates on adoption state.
Recent period
Public evidence
Cognoa’s AI-based autism diagnosis aid gets FDA de novo clearance
SignalHunt:validation:Cognoa
Public evidence
Ability Center brings Cognoa's Canvas Dx to Saudi Arabia
SignalHunt:validation:Cognoa
Public evidence
FDA authorizes Cognoa autism spectrum disorder diagnostic aid
SignalHunt:validation:Cognoa
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 70 public external signal(s) across 3 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Cognoa through regulatory records, deployment evidence, company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand Cognoa. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Canvas Dx is an AI-powered diagnostic tool for children aged 1.5 to 6 years. It assists clinicians by analyzing parent-provided videos and questionnaires to help identify autism spectrum disorder.According to Cognoa
What Cognoa states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The tool uses machine learning to analyze parent-provided video and questionnaire data.
According to Cognoa
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Recent change
Ability Center brings Cognoa's Canvas Dx to Saudi Arabia
Reported publicly
Have you noticed this shift?
Recent change
Cognoa’s AI-based autism diagnosis aid gets FDA de novo clearance
Reported publicly
A matter of record — context, not something practice can confirm.
Recent change
FDA authorizes Cognoa autism spectrum disorder diagnostic aid
Reported publicly
A matter of record — context, not something practice can confirm.
Recent change
Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid
Reported publicly
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
• Product Overview: Cognoa offers Canvas Dx, an AI-powered diagnostic solution designed to assist clinicians in diagnosing or ruling out autism spectrum disorder (ASD) in children aged 1.5 to 6 years. (cognoa.com) • Technical Functionality: Canvas Dx utilizes machine…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings, US
Key strength
Regulatory: FDA-authorized Class II diagnostic medical device, FDA Breakthrough Device Designation
Key capabilities
AI-driven autism diagnostic assessments, Remote evaluation via parent-submitted videos and questionnaires, Data-driven insights supporting clinical decision-making
Clinical use cases
Early autism diagnosis in pediatric clinics, Remote autism assessments for underserved communities, Accelerated referral processes for children with developmental concerns
Who uses it
Pediatricians, Child development specialists, Clinical psychologists
How the reality here has changed
Earlier activity concentrated on accuracy quality, adoption state, time saved. More recent activity concentrates on adoption state.
Earlier
- accuracy quality
- adoption state
- time saved
More recently
- adoption state
Connected intelligence
Category intelligence